510 related articles for article (PubMed ID: 17520180)
1. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.
Konno H; Taylor LS
Pharm Res; 2008 Apr; 25(4):969-78. PubMed ID: 17520180
[TBL] [Abstract][Full Text] [Related]
2. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine.
Konno H; Taylor LS
J Pharm Sci; 2006 Dec; 95(12):2692-705. PubMed ID: 16892209
[TBL] [Abstract][Full Text] [Related]
3. Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions.
Rumondor AC; Stanford LA; Taylor LS
Pharm Res; 2009 Dec; 26(12):2599-606. PubMed ID: 19806435
[TBL] [Abstract][Full Text] [Related]
4. Recrystallization of nifedipine and felodipine from amorphous molecular level solid dispersions containing poly(vinylpyrrolidone) and sorbed water.
Marsac PJ; Konno H; Rumondor AC; Taylor LS
Pharm Res; 2008 Mar; 25(3):647-56. PubMed ID: 17846870
[TBL] [Abstract][Full Text] [Related]
5. Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture.
Rumondor AC; Taylor LS
Mol Pharm; 2010 Apr; 7(2):477-90. PubMed ID: 20039693
[TBL] [Abstract][Full Text] [Related]
6. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).
Marsac PJ; Rumondor AC; Nivens DE; Kestur US; Stanciu L; Taylor LS
J Pharm Sci; 2010 Jan; 99(1):169-85. PubMed ID: 19492305
[TBL] [Abstract][Full Text] [Related]
7. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
[TBL] [Abstract][Full Text] [Related]
8. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
[TBL] [Abstract][Full Text] [Related]
9. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.
Konno H; Handa T; Alonzo DE; Taylor LS
Eur J Pharm Biopharm; 2008 Oct; 70(2):493-9. PubMed ID: 18577451
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
Mahmah O; Tabbakh R; Kelly A; Paradkar A
J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
[TBL] [Abstract][Full Text] [Related]
11. Dissolution and precipitation behavior of amorphous solid dispersions.
Alonzo DE; Gao Y; Zhou D; Mo H; Zhang GGZ; Taylor LS
J Pharm Sci; 2011 Aug; 100(8):3316-3331. PubMed ID: 21607951
[TBL] [Abstract][Full Text] [Related]
12. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J
Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398
[TBL] [Abstract][Full Text] [Related]
13. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
Tian Y; Jones DS; Andrews GP
Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
[TBL] [Abstract][Full Text] [Related]
14. Characterization of moisture-protective polymer coatings using differential scanning calorimetry and dynamic vapor sorption.
Bley O; Siepmann J; Bodmeier R
J Pharm Sci; 2009 Feb; 98(2):651-64. PubMed ID: 18481311
[TBL] [Abstract][Full Text] [Related]
15. Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation.
Van Eerdenbrugh B; Taylor LS
Mol Pharm; 2010 Aug; 7(4):1328-37. PubMed ID: 20536263
[TBL] [Abstract][Full Text] [Related]
16. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
Sarode AL; Malekar SA; Cote C; Worthen DR
Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
[TBL] [Abstract][Full Text] [Related]
17. Effect of Temperature and Moisture on the Physical Stability of Binary and Ternary Amorphous Solid Dispersions of Celecoxib.
Xie T; Taylor LS
J Pharm Sci; 2017 Jan; 106(1):100-110. PubMed ID: 27476771
[TBL] [Abstract][Full Text] [Related]
18. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.
Chen Y; Liu C; Chen Z; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Mol Pharm; 2015 Feb; 12(2):576-89. PubMed ID: 25535667
[TBL] [Abstract][Full Text] [Related]
19. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
[TBL] [Abstract][Full Text] [Related]
20. Physical stability of API/polymer-blend amorphous solid dispersions.
Lehmkemper K; Kyeremateng SO; Bartels M; Degenhardt M; Sadowski G
Eur J Pharm Biopharm; 2018 Mar; 124():147-157. PubMed ID: 29269154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]